The long-term goal of this application is to investigate the role of maspin in prostate tumor progression. Maspin is a novel epithelial-specific serine protease inhibitor (serpin) with tumor suppressive activities. Our study in the last funding period yielded several major breakthroughs including: (i) the discovery of a specific cell surface-dependent interaction between maspin and the uPA/uPAR complex (ii) maspin sensitizes tumor, but not normal, cells to induced apoptosis; (iii) Maspin induces tumor redifferentiation in vivo; (iv) maspin inhibits prostate tumor growth in human bone microenviroment and inhibits prostate tumor-induced osteolysis and angiogenesis. Our additional evidence further suggests that maspin enhances cell-cell interaction, retards cellmatrix dissociation, and inhibits oxidative stress-induced reactive oxygen species (ROS) generation. While recent X-ray crystal structural analyses confirm that maspin has a general framework conserved among most serpins but is metastable, the evidence that systemic maspin knockout is lethal at embryogenesis clearly indicates a uniquely critical function of maspin that can not be complemented by other molecules. In view of the multifaceted functionalities of maspin, it is of paramount importance to identify its molecular partners. In our further studies, the multifunctional low density lipoprotein related protein (LRP), and pro-uPA were identified as potential extracellular targets of maspin, while glutathione S-transferase (GST), Heat shock protein-90 (Hsp90) and histone deacetylase 1 (HDAC1) were identified as potential intracellular targets of maspin. For the first time, all evidence seems to consistently support one mode of maspin action: it acts as a stress-responsive chaperone. Together with the novel biphasic maspin expression pattern in early prostate cancer development, our data led to a novel Hypothesis that maspin plays an important role in the regulation of epithelial response to changes of the microenvironment.
Three aims are designed to test this hypothesis.
Specific Aim 1 : To test the hypothesis that maspin chaperones and regulates the LRP-controlled cell surface presentation and activity of external stimuli;
Specific Aim 2 : To investigate the molecular mechanisms underlying the maspin effects on GST, Hsp90 and HDAC1-mediated intracellular stress-response pathways;
and Specific Aim 3 : To investigate the biological effect of maspin in prostate development and tumor progression in vivo. The proposed study is expected to generate paradigm-shifting evidence regarding the molecular mechanism of maspin. Consequently, the expected results will further define the potential utility of maspin-based therapeutic strategies

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA084176-05S2
Application #
7477453
Study Section
Pathology B Study Section (PTHB)
Program Officer
Mohla, Suresh
Project Start
2001-01-01
Project End
2008-08-31
Budget Start
2005-01-01
Budget End
2008-08-31
Support Year
5
Fiscal Year
2007
Total Cost
$74,504
Indirect Cost
Name
Wayne State University
Department
Pathology
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Dzinic, Sijana H; Bernardo, M Margarida; Li, Xiaohua et al. (2017) An Essential Role of Maspin in Embryogenesis and Tumor Suppression. Cancer Res 77:886-896
Bernardo, Margarida M; Dzinic, Sijana H; Matta, Maria J et al. (2017) The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin. J Cell Biochem 118:1639-1647
Thakur, Manish K; Heilbrun, Lance K; Sheng, Shijie et al. (2016) A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study. Invest New Drugs 34:112-8
Dzinic, Sijana H; Bernardo, Maria M; Oliveira, Daniel S M et al. (2015) Tumor suppressor maspin as a modulator of host immune response to cancer. Bosn J Basic Med Sci 15:1-6
Bernardo, M Margarida; Kaplun, Alexander; Dzinic, Sijana H et al. (2015) Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity. Cancer Res 75:3970-9
Dzinic, Sijana H; Chen, Kang; Thakur, Archana et al. (2014) Maspin expression in prostate tumor elicits host anti-tumor immunity. Oncotarget 5:11225-36
Wang, Yang; Sheng, Shijie; Zhang, Jianzhi et al. (2013) Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC). PLoS One 8:e63581
Dzinic, Sijana H; Kaplun, Alexander; Li, Xiaohua et al. (2013) Identification of an intrinsic determinant critical for maspin subcellular localization and function. PLoS One 8:e74502
Kaplun, Alexander; Dzinic, Sijana; Bernardo, M et al. (2012) Tumor suppressor maspin as a rheostat in HDAC regulation to achieve the fine-tuning of epithelial homeostasis. Crit Rev Eukaryot Gene Expr 22:249-58
Li, Xiaohua; Kaplun, Alexander; Lonardo, Fulvio et al. (2011) HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells. Mol Cancer Res 9:733-45

Showing the most recent 10 out of 22 publications